Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (31)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Kousta, E.
Right arrow Articles by Franks, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kousta, E.
Right arrow Articles by Franks, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 11, 2720-2723, November 1999
© 1999 European Society of Human Reproduction and Embryology

The prevalence of polycystic ovaries in women with infertility

E. Kousta1,3, D.M. White2, E. Cela2, M.I. McCarthy1 and S. Franks2

1 Section of Endocrinology and Metabolic Medicine and 2 Department of Reproductive Science and Medicine, Imperial College School of Medicine, St Mary's Hospital, London W2 1PG, UK

Polycystic ovaries (PCO) are highly prevalent in women presenting with hirsutism or recurrent miscarriage but the functional significance of PCO in ovulatory women presenting with infertility remains unclear. We examined the prevalence of PCO, on ultrasonography, among women presenting with infertility. Among 289 couples classified in four main diagnostic categories, PCO were found in 81 (83%) of 98 anovulatory patients, 40 (53%) of 76 patients whose partners had sperm dysfunction, 26 (50%) of 52 patients with tubal disease and in 28 (44%) of 63 patients with unexplained infertility. By comparison, in a control group of 67 parous volunteers, 19 (28%) were found to have PCO. PCO patients with unexplained infertility had higher midfollicular luteinizing hormone and testosterone compared with the group with normal ovaries. The prevalence of PCO was significantly higher in each of the infertility groups than in controls, and a similar tendency (not significant) was observed among women with unexplained infertility. Ovulatory PCO women with infertility had higher testosterone concentrations in comparison with PCO controls. In summary, the prevalence of PCO among ovulatory women with infertility is higher than that in the normal population, suggesting that PCO may, perhaps by virtue of an effect of hyperandrogenaemia, contribute to the causes of subfertility in women with regular menses.

Key words: infertility/ovulation/polycystic ovaries

3 To whom correspondence should be addressed


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
L. Moran and H. Teede
Metabolic features of the reproductive phenotypes of polycystic ovary syndrome
Hum. Reprod. Update, July 1, 2009; 15(4): 477 - 488.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. Yesilada, I. Sahin, H. Ozcan, I. H. Yildirim, S. Yologlu, and C. Taskapan
Increased micronucleus frequencies in peripheral blood lymphocytes in women with polycystic ovary syndrome.
Eur. J. Endocrinol., April 1, 2006; 154(4): 563 - 568.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. Azziz
Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature
J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 781 - 785.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Schmid, S. Kirchengast, E. Vytiska-Binstorfer, and J. Huber
Infertility caused by PCOS--health-related quality of life among Austrian and Moslem immigrant women in Austria
Hum. Reprod., October 1, 2004; 19(10): 2251 - 2257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Sekar and J. D. Veldhuis
Involvement of Sp1 and SREBP-1a in transcriptional activation of the LDL receptor gene by insulin and LH in cultured porcine granulosa-luteal cells
Am J Physiol Endocrinol Metab, July 1, 2004; 287(1): E128 - E135.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Homburg
What is polycystic ovarian syndrome?: A proposal for a consensus on the definition and diagnosis of polycystic ovarian syndrome
Hum. Reprod., October 1, 2002; 17(10): 2495 - 2499.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Joseph-Horne, H. Mason, S. Batty, D. White, S. Hillier, M. Urquhart, and S. Franks
Luteal phase progesterone excretion in ovulatory women with polycystic ovaries
Hum. Reprod., June 1, 2002; 17(6): 1459 - 1463.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S.A.K.S. Amer, T.C. Li, C. Bygrave, A. Sprigg, H. Saravelos, and I.D. Cooke
An evaluation of the inter-observer and intra-observer variability of the ultrasound diagnosis of polycystic ovaries
Hum. Reprod., June 1, 2002; 17(6): 1616 - 1622.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H.-A. Pan, M.-H. Wu, Y.-C. Cheng, C.-H. Li, and F.-M. Chang
Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis
Hum. Reprod., January 1, 2002; 17(1): 201 - 206.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Kirchengast and J. Huber
Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome
Hum. Reprod., June 1, 2001; 16(6): 1255 - 1260.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.